Informed Consent for Hi-Dose Major Autohemotherapy with UBI IV Treatment
Patient Information
Patient Name:
Today's Date:
Date of Birth:
Email:
Phone:
Introduction
This document provides information about Hi-Dose (HD) Major Autohemotherapy (MAH) and Ultraviolet Blood Irradiation (UBI) with intravenous administration. It is important to read and understand this before giving consent. This therapy is NOT FDA approved. HD O3UV involves withdrawal of ~300 ml of blood, mixing with medical-grade ozone, passing through UV light twice, and re-infusing. Intended to enhance oxygen utilization, improve circulation, and support the immune system. Procedure, benefits, risks, alternatives, contraindications, and responsibilities are explained in full above.
Required Attestations
Contraindications
Select any that apply (leave blank if none):
Patient Responsibilities
Confidentiality
Signatures
Patient Signature (type full name):
Date:
Print Name:
Provider Signature: "Scarlet Drip"